This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

UGP281

Unigene Laboratories, Inc.

Drug Names(s): UGP281

Description: UGP281 is a potent anorexigenic peptide selectively targeting the amylin receptor designed to diminish or control appetite and weightloss in morbidly obese patients.


UGP281 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug